Company intelligence / Profile preview

Lennox Capital Partners

Sydney, New South Wales, Australialennoxcpllc.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Lennox Capital Partners manages actively managed funds focused on Australian small-cap listed equities. The firm has a track record of identifying high-growth potential companies across various sectors, including healthcare and biotechnology. Its flagship fund typically holds 20–40 positions and aims to outperform the S&P/ASX Small Ordinaries Accumulation Index over the medium to long term. Recent top holdings include Botanix Pharmaceuticals (dermatology), Integral Diagnostics (healthcare services), among others.

Industry: Investors

Beyond the preview

Go deeper on Lennox Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lennox Capital Partners.

Explore the full profile